Opsoclonus-Myoclonus Syndrome or OMS (also known as the “dancing eyes” syndrome) affects roughly 1 in every 200 patients with neuroblastoma, a cancer of the sympathetic nervous system.
Investigators at Children’s Hospital Los Angeles found that differences between the sexes are present at birth. Results of the study were published in the August 2015 issue of the Journal of
Dr. Johanna Olson and team have made a significant finding: transgender individuals have sex hormone levels consistent with the sex they were assigned at birth.
Retinoblastoma is a common eye cancer in children. David Cobrinik of The Vision Center has helped answer the question of why mutations to the RB1 gene primarily cause tumors of the retina.
A recent study found that the growth factor G-CSF, used in high-risk neuroblastoma treatment, leads to increased tumor growth and metastasis. Investigators think the benefits still outweigh the risks.
The massive size of diagnostic imaging files has made remote sharing difficult. Stephan Erberich and Marvin Nelson have created an app that makes it easy while protecting patient privacy.
Hisham Abdel-Azim led a team of investigators that determined that minimal residual disease at the end of induction therapy did not predict outcome in children with T-acute lymphoblastic leukemia.